MeSH Review:
Raynaud Disease
- Topical glyceryl trinitrate as adjunctive treatment in Raynaud's disease. Franks, A.G. Lancet (1982)
- Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Wigley, F.M., Wise, R.A., Seibold, J.R., McCloskey, D.A., Kujala, G., Medsger, T.A., Steen, V.D., Varga, J., Jimenez, S., Mayes, M., Clements, P.J., Weiner, S.R., Porter, J., Ellman, M., Wise, C., Kaufman, L.D., Williams, J., Dole, W. Ann. Intern. Med. (1994)
- Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients. Alonso-Ruiz, A., Calabozo, M., Perez-Ruiz, F., Mancebo, L. Medicine (Baltimore) (1993)
- Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Vaerøy, H., Helle, R., Førre, O., Kåss, E., Terenius, L. Pain (1988)
- Arteriovenous reversal for limb salvage in unreconstructible upper extremity arterial occlusive disease. King, T.A., Marks, J., Berrettoni, B.A., Seitz, W.H. J. Vasc. Surg. (1993)
- Venodilation in Raynaud's disease. Bedarida, G., Kim, D., Blaschke, T.F., Hoffman, B.B. Lancet (1993)
- Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Zamora, M.R., O'Brien, R.F., Rutherford, R.B., Weil, J.V. Lancet (1990)
- Nifedipine in the treatment of Raynaud's disease in childhood. Kaya, I.S., Senses, D.A., Dilmen, U. Lancet (1989)
- Rapid effect of oral limaprost in Raynaud's disease in childhood. Shono, T., Ikeda, K. Lancet (1989)
- Cyclosporin and Raynaud phenomenon. Deray, G., Le Hoang, P., Achour, L., Hornych, A., Landault, C., Caraillon, A. Lancet (1986)
- Treatment of childhood Raynaud's disease by transdermal prostaglandin E2 analogue. Dunger, D.B., Dillon, M.J., Daman-Willems, C., Cooke, E.D., Bowcock, S.A. Lancet (1985)
- Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Badesch, D.B., Tapson, V.F., McGoon, M.D., Brundage, B.H., Rubin, L.J., Wigley, F.M., Rich, S., Barst, R.J., Barrett, P.S., Kral, K.M., Jöbsis, M.M., Loyd, J.E., Murali, S., Frost, A., Girgis, R., Bourge, R.C., Ralph, D.D., Elliott, C.G., Hill, N.S., Langleben, D., Schilz, R.J., McLaughlin, V.V., Robbins, I.M., Groves, B.M., Shapiro, S., Medsger, T.A. Ann. Intern. Med. (2000)
- The association of estrogen replacement therapy and the Raynaud phenomenon in postmenopausal women. Fraenkel, L., Zhang, Y., Chaisson, C.E., Evans, S.R., Wilson, P.W., Felson, D.T. Ann. Intern. Med. (1998)
- Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. D'Alonzo, G.E., Barst, R.J., Ayres, S.M., Bergofsky, E.H., Brundage, B.H., Detre, K.M., Fishman, A.P., Goldring, R.M., Groves, B.M., Kernis, J.T. Ann. Intern. Med. (1991)
- The importance of presynaptic beta receptors in Raynaud's disease. Brotzu, G., Falchi, S., Mannu, B., Montisci, R., Petruzzo, P., Staico, R. J. Vasc. Surg. (1989)
- Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynauds syndrome. Belch, J.J., McLaren, M., Anderson, J., Lowe, G.D., Sturrock, R.D., Capell, H.A., Forbes, C.D. Prostaglandins, leukotrienes, and medicine. (1985)
- In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: IV. In vitro bioassay of the vasoinhibitory activity of sera from patients suffering from peripheral ischaemia. Kaada, B., Helle, K.B. Gen. Pharmacol. (1984)
- Increased tyrosine phosphorylation mediates the cooling-induced contraction and increased vascular reactivity of Raynaud's disease. Furspan, P.B., Chatterjee, S., Freedman, R.R. Arthritis Rheum. (2004)
- Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients. Farber, S.J., Bole, G.G. Arch. Intern. Med. (1976)
- Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease. Caglayan, E., Huntgeburth, M., Karasch, T., Weihrauch, J., Hunzelmann, N., Krieg, T., Erdmann, E., Rosenkranz, S. Arch. Intern. Med. (2006)
- Prolonged effect of CGRP in Raynaud's patients: a double-blind randomised comparison with prostacyclin. Shawket, S., Dickerson, C., Hazleman, B., Brown, M.J. British journal of clinical pharmacology. (1991)
- Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker. Rupp, P.A., Mellinger, S., Kohler, J., Dorsey, J.K., Furst, D.E. J. Rheumatol. (1987)
- The diagnosis and treatment of Raynaud's phenomenon. Porter, J.M., Snider, R.L., Bardana, E.J., Rösch, J., Eidemiller, L.R. Surgery (1975)
- Ketanserin: a novel cardiovascular drug. Symoens, J. Blood Coagul. Fibrinolysis (1990)